chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; Fever chills fatigue feeling not well aches severe nausea headache; This is a spontaneous report received from a contactable consumer, the patient. A 59-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6207), via an unspecified route of administration, administered in left arm on 17Mar2021 15:30 (at the age of 59-years-old) as dose1, single for covid-19 immunization. Medical history included fibromyalgia, gastrooesophageal reflux disease(GERD), irritable bowel syndrome. The patient had allergies to morphine, levsin. Concomitant medications and received within 2 weeks of vaccination included zolpidem tartrate (AMBIEN); famotidine; paracetamol (TYLENOL). The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 18Mar2021, the patient experienced fever, chills, fatigue, feeling not well, aches, severe nausea, headache. The patient did not receive any treatment. Outcome of all the events was not resolved.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
STARTING HAVE SEVERE PAIN IN LOWER NECK UP INTO LEFT SIDE OF HEAD SEVERAL DAYS AFTER VACCINE. ER ON 3/15/21 SHOWED ARTHRITIS IN C-3. SENT TO DR FOR FOLLOW UP. 3/17/21 PUT ON ORAL PREDNISONE, PAIN SHOTS X4 IN AREA. 3/19/21 RETURN TO ER, INCREASED PAIN AGAIN, LOSE OF SIGHT IN LEFT EYE, CT SHOWED POSSIBLE VERTEBRAL ARTERIAL OCCLUSION WITH POSSIBLE DISECTION. ADMITTED. ALSO SAW MICRO VASCULAR CHANGES AND ATROPHY. NEURO CONSULT FOR THROMBECTOMY VS MEDICATION MANAGEMENT. PER FAMILY, PAIN MEDS, NO FURTHER MRI OF BRAIN, COMFORT CARES. PT DIED 3/22/21.
Physician reported that patient received Prevnar, Comvax (Merck), and Varivax (Merck) on 11/01/00. Within 12 hours post immunization, he developed vomiting. The physician indicated that as of 11/05/00, the patient has vomited once each day since vaccination. This is 1 of 3 children from this facility who has had an adverse experience following receipt of Prevnar. Additional information received 12/29/2000 indicated the patient recovered.
Shortly after 12 month vaccines, the patient developed bilateral lower extremity swelling below the knee along with redness, swelling and heat. He was given BENADRYL and cold packs and after a few minutes the swelling appeared to be going away. There was no shortness of breath or other symptoms.
GI symptoms, diarrhea; No appetite; Lost her taste; lost her sense of smell; couldn't move her arm, as if "arm was stuck to my body"; rash; Severe headache; Exhaustion; Chills; This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (GI symptoms, diarrhea), DECREASED APPETITE (No appetite), AGEUSIA (Lost her taste ), ANOSMIA (lost her sense of smell ) and LIMB DISCOMFORT (couldn't move her arm, as if "arm was stuck to my body") in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 03-Dec-2020 to 13-Dec-2020 and IgG subclass deficiency (Source states:  IgG3 Deficiency).    On 27-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, the patient experienced DIARRHOEA (GI symptoms, diarrhea), DECREASED APPETITE (No appetite), AGEUSIA (Lost her taste ), ANOSMIA (lost her sense of smell ), LIMB DISCOMFORT (couldn't move her arm, as if "arm was stuck to my body"), RASH (rash ), HEADACHE (Severe headache), FATIGUE (Exhaustion) and CHILLS (Chills). On 31-Dec-2020, DIARRHOEA (GI symptoms, diarrhea), DECREASED APPETITE (No appetite), AGEUSIA (Lost her taste ), ANOSMIA (lost her sense of smell ), LIMB DISCOMFORT (couldn't move her arm, as if "arm was stuck to my body"), RASH (rash ), HEADACHE (Severe headache), FATIGUE (Exhaustion) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
got the shot, but still had shingles; still had shingles/Worse than poison ivy; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the shot, but still had shingles) (serious criteria GSK medically significant) and shingles (Verbatim: still had shingles/Worse than poison ivy). The outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 16-Mar-2023 The case was received from the patient via  interactive digital media. The patient got the shot, but still had shingles. The patient stated worse than poison. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
No adverse effect reported; patient was inadvertently administered a dose of PROQUAD that had been improperly stored; This spontaneous report was received from a vaccine coordinator referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and drug reactions/allergies were not provided.   On 24-SEP-2019, the patient was inadvertently vaccinated with  improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # R030805 (verified to be a valid lot number), expiration date reported and established as 22-APR-2020 and lot #S003326 (verified to be a valid lot number), expiration date reported and established as 02-AUG-2020, both for prophylaxis and reconstituted with a properly stored sterile diluent. Both lots were improperly stored at 27.1°F during a time frame of 40 minutes. The call was because of a data logger. No adverse effect neither previous temperature excursions were reported.
Fever day after vaccination, st, slight nausea.  Pt states higher fever 1-8-2012 T103.  No treatment, monitor seen 1-9-2012 T99, feeling better possibly viral illness.
felt congested; worried; This is a spontaneous report from a non-contactable nurse. A patient of unspecified age and gender started to received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 02Jan201, the patient felt congested and worried. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This is a spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of an unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with maximum temperature (Tmax) 8.2 degree centigrade for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree centigrade for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 centigrade for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 31-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 252672 and expiry date: 30-Jun-2019) which underwent temperature excursion. The patient did not experience any adverse events after administered. This case is linked to 201805262 (same reporter).
redness at shot sight from time of vaccine through and including February 26th, pain in left arm down to left wrist extending up neck into left side of face, extreme tiredness, nausea, on February 25th was getting out of the shower and had two episodes of throat closing like I was being chocked
pt recv vax 30SEP97 & 4OCT97 pt devel chickenpox w/o a fever;
Contracted COVID-19; Contracted COVID-19; Dose number = 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Oct2021 (Lot number: EW0217) at the age of 48 years as dose 3 (booster), single, administered in arm left, administration date 16Feb2021 (Lot number: EL3247) as dose 2, single and administered in arm left, administration date 27Jan2021 (Lot number: EL3247) as dose 1, single for covid-19 immunisation; influenza vaccine (FLU), administered in arm right, administration date 27Oct2021 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "GERD" (unspecified if ongoing), notes: Known allergies: No. Concomitant medication(s) included: PEPCID AC. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 27Dec2021, outcome "recovering" and all described as "Contracted COVID-19"; IMMUNISATION (medically significant) with onset 27Oct2021, outcome "unknown", described as "Dose number = 3". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (29Dec2021) positive, notes: Post vaccination: Nasal Swab; (31Dec2021) positive, notes: Post vaccination: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.  Clinical information: Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Recd vaccine on Tues. 3/2/09 about 10 am. No immediate reaction. Wed. am patient noticed itching. by Wed. afternoon, area of injection red, swollen, hard and hot. Pt applied ice and DIPHENHYDRAMINE cream with minimal results MD seen. DX: cellulitis. Rx: CEPH 500 qid & ATARAX 25 q6h prn.
Extreme weakness, Fever  up to 102.0, Heavy chills, loose, frequent stools
Lips blew up and inflamed lips, cankers sore on right  outer lip, only 1 in mouth.  No saliva, hard to talk and eat, fluids came out the sides of the mouth.   Lasted 6 weeks.  only help was told to go to ER.   Not with virus in hospitals.    Went on line and asked if anyone had the same adverse reaction. Found out about   a lady who was identical to mine.  got a steroid cream and started to get better.
S/S injection site swelled to baseball size is red and warm. Was given Children's Ibuprofen at clinic. Advised to take BENADRYL and ice pack to put on arm at home.
Dizziness, soft ball sized swelling on left posterior upper arm at injection site, with localized heat and pain, prompting ER visit, on Saturday evening.
p/vax on sep 3 rash penis; sep 20 vertigo x 3 episodes; syncope; apr-sep fatigue;still some vertigo
PATIENT GIVEN 3RD COVID 19 VACCINE ON 10/28/2021 - MODERNA LOT#012F21A. PATIENT DIED OF COVID 08/18/2022.
8 days post injection I was directed to go to urgent care by my primary physician. They said it looked like cellulitis and drew a circle around it. It continued to rapidly grow and I was told to go to the emergency room. At the ER I was told it looked more like a reaction to the vaccine as there was no entry spot for the bacterial infection.  I was told to complete the oral antibiotics. 24 hours later there was still swelling and spreading and I was given a second oral antibiotic to take at the same time.
ED/Hospitalization within 6 weeks of receiving COVID vaccination. ED visit 1/23/22 for right calf pain. Hospitalization 1/29/22 for Acute encephalopathy.
severe headache, fever, dizziness, nausea/vomiting, achiness, fatigue
Developed swelling, redness, pain at injection site of last 2 anthrax vaccines he received.
Symptoms: chills, high fever, body aches, strong headache;  Treatment: Extra Strength Tylenol (500mg)
pain at site of injection, fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, fever, lightheadedness and inability to perform daily tasks. Lasting approximately 15 hours.
1ST DOSE ENGERIX-B 3-15-90, ONSET OF UNILAT NUMBNESS & TINGLING(RT HAND & FOOT) ON 3-29-90.  AS OF 4-12-90 COND. PERSISTS. F/U 11FEB91:  MD FELT THERE WAS A POSSIBILITY OF A PRIMARY NEURO PROBLEM AND THAT IT'S ?ABLE IF SXS D/T VAC.
Ocular migrane; Blurred vision; Dizziness; Headache; This is a spontaneous report from a contactable consumer (patient). A 46-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 25May2021 15:00 (at the age of 46-years-old) (Batch/Lot Number: EW0191) as single dose for COVID-19 immunisation. Medical history included thyroid cancer, asthma, degenerative joints. Concomitant medication(s) included levothyroxine; meloxicam; etanercept (ENBREL), all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine in four weeks. The patient previously took PERCOCET [oxycodone hydrochloride;paracetamol] and experienced allergy. The patient had no covid prior vaccination. On 04Jun2021, the patient experienced ocular migraine, blurred vision followed by dizziness and headache. The patient did not receive any treatment for the events. The patient had no tested covid post vaccination. Outcome of the events was not recovered.  Follow-up activities closed no further information expected.
shingles; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 4ME42, expiry date 21st November 2021) for prophylaxis.   On 24th March 2020, the patient received the 1st dose of Shingrix. On 5th May 2020, 42 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: Nurse reported that a patient developed shingles after receipt of his first dose of Shingrix.
had symptoms for 3-4 days; body ache; tiredness; fever; This case was reported by a consumer and described the occurrence of influenza-like symptoms in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st January 2020, the patient received the 1st dose of Shingrix 50 mcg/mg. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced influenza-like symptoms, general body pain, tiredness and fever. On an unknown date, the outcome of the influenza-like symptoms, general body pain, tiredness and fever were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, general body pain, tiredness and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received vaccine and had flu-like symptoms for 3-4 days afterward - body ache, tiredness, and fever.  The patient was very reluctant to get their second dose because of initial reaction. Those side effects were like COVID-19.
Patient reports tear in esophagus on 3/24/21 in the evening whenever she felt sick to her stomach. She did not feel well, drank one beer, and ate a packet of tuna. She continued to not feel well and felt the food did not go down correctly, so she reached into her throat and noticed blood. She called her doctor and the doctor recommended monitoring for increased bleeding. Later that night, she reports not feeling well again, made herself throw up, and noticed the vomit was all blood. The patient then called 9-1-1, and presents to the hospital. During the hospital visit she noticed that she saw 'blood clots about the size of a quarter' when she went to the bathroom. Patient reports the hospital gave her 4 pints of blood, 4 bags of 'yellow stuff' (patient assumes its plasma), protonix, antibiotics, and NS. Patient was in the ICU and reports being in the hospital for about 5 days total, whenever the doctor recommended being put on hospice. The patient did want to be put on hospice and wants to be treated, so she contacted her heart doctor and is waiting on an appointment with him on the 28th of April. Patient reports that doctor told her that she 'needs a new heart', but that she is not a good candidate, and that the Dr. told her this just a day or two ago. Patient reports that she did not know it was a tear in her throat (esophagus) until they "stuck a scope down there".
On Sat 2/6 at around 8 PM I had a scary episode of nystagmus in my left eye with dizziness that lasted around 15 seconds. This was the first time I?ve ever had this happen.
Daughter is only 15.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter is only 15.) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter is only 15.). On 21-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Daughter is only 15.) had resolved.            No concomitant medications were reported.   No corrective treatment was provided.
devel mild erythema multiforme 1/2 day p/recvd acellular DTP also finished bactrim 2 day a/;
This case meets vaccine breakthrough criteria .  SXS INCLUDE GENERAL MALAISE, FEVER, MUSCLE PAINS, COUGH, SOB
A little achy; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (A little achy) and FATIGUE (Felt tired) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for Asthma, HYDROCHLOROTHIAZIDE for an unknown indication.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (A little achy) and FATIGUE (Felt tired). At the time of the report, PAIN (A little achy) and FATIGUE (Felt tired) outcome was unknown.            No concomitant product use was provided by the reporter. No treatment medication was provided.   This case was linked to MOD-2021-398593 (Patient Link).
10 years old daughter had her first dose; 10 years old daughter had her first dose; Legs and ankles are bothering; having problem with her ankles; Legs and ankles are bothering; having problem with her ankles; Joint pain; she had a lot of pain in her ankles; This is a spontaneous report received from a contactable consumer (patient's mother) via a Pfizer Sponsored Program.   A 10 years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN2613 and expiration date: not reported), via an unspecified route of administration, on 02Apr2021 (age at vaccination was 10 Years) as dose 1, single for COVID-19 immunization. Patient Medical History included ongoing allergy from an unknown date. Concomitant medication included loratadine, pseudoephedrine sulfate (CLARITIN-D) taken for an allergy, start and stop date were not reported. On an unspecified date, the patient experienced 10 years old daughter had her first dose, legs and ankles were bothering, having problem with her ankles and joint pain. The consumer reported that 10 years old daughter had her first dose and denied scheduled second dose; should have not given because she has not even menstruating. Reporter stated her daughter had her first dose of the COVID vaccine on 02Apr2021, the vaccine administrator asked her age and still gave the vaccine and the second dose vaccine receiving was today on 14May2021. Caller wanted to know that was there was any long term effect for her 10 year old. When probed any side effects from the first shot, reporter stated that the patient took Naproxen (treatment), she had a lot of pain in her ankles and it was bothering her a lot that was all. It did actually she had a lot of problem since the shot, her legs and ankles were bothering her. She was in gymnastics, so she started having problem with her ankles. She further had joint pain, her ankles and her legs have been bothering. She was also being exercising. Investigation Assessment: No. Outcome of all events was Unknown.  No follow up attempts are needed. No further information is expected.
Moderna vaccine was administered outside of clinic- reported by patient ? NO LOT NUMBER WERE SUPPLIED   EPILEPSY, UNSPECIFIED 6/10/2021 HTN (HYPERTENSION)  EPILEPSY, UNSPECIFIED 6/10/2021 ALTERED MENTAL STATUS, UNSPECIFIED
Per pt - In middle of night awoke feeling nausea. Did not vomit. Arm is sore? Hard where vaccine was administered.
This case was reported by a healthcare professional and described the occurrence of hives in a 6-month-old male subject who was vaccinated with Engerix B (GlaxoSmithKline), Infanrix for prophylaxis.  The subject's medical history and concurrent conditions were not provided.  The subject had no known concurrent medications.  Previous and/or concurrent vaccination included Comvax; Merck given on 27 February 2006; Prevnar; Wyeth Labs given on 27 February 2006.  On 27 February 2006 the subject received 1st dose of Engerix B (unknown, right thigh, lot number reported as "ACHBCC6AA") and the 1st dose of Infanrix (unknown).  (A lot number that was given appears to be that of Infanrix; however, Infanrix was not mentioned in the subject's chart.)  At an unspecified time after vaccination with Engerix B and Infanrix, the subject experienced hives.  The reporter, a nurse, was calling from an allergist's office.  They were trying to determine the causative allergen of the hives.  The Engerix B immunization series was delayed and discontinued.  At the time of reporting, the hives resolved.